WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'5601 Infant (under 12 months) mortality rate: 152
GDP / capita (US$): 12'3711 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 48'321  47'704  47'079  46'445  45'803  39'898  33'307  26'935 
Births 907  912  915  918  921  914  908  853 
Surviving infants 893  896  900  902  904  894  880  811 
Pop. less than 5 years 4'502  4'521  4'528  4'515  4'512  4'454  4'276  3'915 
Pop. less than 15 years 13'379  13'381  13'375  13'358  13'355  13'101  12'181  11'001 
Female 15-49 years 13'038  12'915  12'783  12'645  12'495  10'894  8'733  6'532 

Number of reported case

(Click for retrospective incidence data for Colombia)
Diphtheria 11  16 
Japanese encephalitis
Measles 12'520  9'222 
Mumps 7'884  9'397  15'926  10'376  9'457 
Pertussis 13'682  3'289  1'010  344  407  446  1'961  7'664 
Polio* 129 
Rubella 157 
Rubella (CRS)
Tetanus (neonatal) 10  133 
Tetanus (total) 31  50  37  71  40  27  167  593 
Yellow fever 11 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Colombia)
Vaccine year result method % card seen                                                
BCG 2009  97  DHS   83  85  89  83  84  90  91  95  45 
DTP1 2009  97  DHS   83  89  91  84  81  91  75 
DTP3 2009  90  DHS   83  91  91  85  88  92  79  88  16 
HepB_BD          82  84  85  74  89  82 
HepB3 2009  90  DHS   83  91  92  85  88  92  78 
Hib3 2009  90  DHS   83  91  91  85  88  92  65 
JapEnc         
MCV 2009  81  DHS   83  92  94  88  89  95  80  82  13 
MCV2          68  79  76  73  71  84 
PCV1          89  94  81  99*  99 
PCV3          87  84  46  71 
Pol3 2009  82  DHS   83  91  91  85  88  92  82  93  16 
Rota1          86  88  80  76  78 
Rota_last          87  87  78  74  82 
Rubella1          92  94  88  89  95 
TT2plus 1994  57  DHS   47  33  42  80  84  55 
PAB         
VAD1         
YFV 2009  77  DHS   83  92  92  88  79  95 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Colombia)
BCG 85  89  83  84  90  91  95  45 
DTP1 97  91  95  96  97  91  96  39 
DTP3 91  91  85  88  92  79  88  16 
HepB3 91  92  85  88  92  78 
HepB_BD 82  89  85  87  89  82 
Hib3 91  91  85  88  92  65 
MCV 92  94  88  88  89  88  82  13 
MCV2 67  80  76  74  71  84 
PAB 79  79  79  79  78  70  45 
PCV3 87  84  46  22 
Pol3 91  91  85  88  92  82  93  16 
Rota_last 87  87  78  74  55 
YFV 92  92  88  79  80 

Number of districts in the country 1'122  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 23
From 50 to 79% 31
Less than 50% 6
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 18 months; 5 years; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 4, 6 months;
HPV 9-17 years; +11 months and 29 days;
HepA 1 year; Yes
HepB birth; Yes At subnational also given to at risk population
IPV 2, 4, 6, 18 months; 5 years Yes immunocompromised
Influenza 6-23 months; +4 weeks; 18-23 months; >60 years; Yes and pregnant women
MMR 1, 5 years; Yes
MR 10-20 years; No or other age groups
OPV 2, 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months;+1, +1 years; Yes For CBAW or pregnant in risk areas
Tdap No for PW in risk areas from March 2013
YF 1 year; Yes and people from 1-60 years in risk areas and travellers

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2019  2010-2014    2011-2014  2007-2010  2008-2011   
Nº of districts with microplans that include activities to raise immunization coverage number   80  1'123  1'123  1'119  1'119  1'119 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 1'122  1'122  1'123  1'123  1'123  1'120  1'119 
Nº districts with DTP3 coverage >=80% number 710  853  474  551  645  640  175 
% of districts with DTP3 coverage >=80% From 0 to 100% 63  76  42  49  57  57  16 
Nº districts with measles (MCV1) coverage >=95% number 393  480  288  277  434  377   
% of districts with MCV1 coverage >=95% From 0 to 100% 35  43  26  25  39  34   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.